Clinical Trials
3
Active:0
Completed:3
Trial Phases
3 Phases
Phase 2:1
Phase 3:1
Phase 4:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Phase 2
1 (33.3%)Phase 3
1 (33.3%)Phase 4
1 (33.3%)A Real-world Study of DEXYCU in the Treatment of Inflammation After Cataract Surgery
Phase 4
Completed
- Conditions
- InflammationCataract
- Interventions
- Drug: Dexycu
- First Posted Date
- 2024-07-12
- Last Posted Date
- 2024-07-12
- Lead Sponsor
- Ocumension Therapeutics (Shanghai) Co., Ltd
- Target Recruit Count
- 263
- Registration Number
- NCT06497699
- Locations
- 🇨🇳
Hainan Traditional Chinese Medicine Hospital, Haikou, Hainan, China
🇨🇳Boao Super Hospital, Bo'ao, China
Study of OT202 in Treating Moderate to Severe Dry Eye
Phase 2
Completed
- Conditions
- Dry Eye
- Interventions
- Drug: PlaceboDrug: OT202 conc 0.1%Drug: OT202 conc 0.5%
- First Posted Date
- 2024-05-30
- Last Posted Date
- 2024-05-30
- Lead Sponsor
- Ocumension Therapeutics (Shanghai) Co., Ltd
- Target Recruit Count
- 213
- Registration Number
- NCT06435182
- Locations
- 🇨🇳
The Third Xiangya Hospital Of Central South University, Changsha, China
🇨🇳The Second Affiliated Hospital Zhejiang University School of Medicine, Hangzhou, China
🇨🇳Then Second People's Hospital of Yunnan Province, Kunming, China
Study of Dexycu in Treating Intraocular Inflammation
Phase 3
Completed
- Conditions
- InflammationCataract
- Interventions
- Drug: DexycuDrug: Placebo
- First Posted Date
- 2024-05-24
- Last Posted Date
- 2024-08-26
- Lead Sponsor
- Ocumension Therapeutics (Shanghai) Co., Ltd
- Target Recruit Count
- 285
- Registration Number
- NCT06429306
- Locations
- 🇨🇳
Shanghai General Hospital, Shanghai, China
News
No news found